European Commission Reaffirms Titanium Dioxide’s Use in Medicinal Products
October 03 2025
On August 6, 2025, the European Commission published a document reaffirming TiO₂’s use in medicinal products under Regulation (EU) 2022/63. This followed the European Medicines Agency’s (EMA) April 2024 review, which concluded that TiO₂ is irreplaceable for ensuring drug quality, safety, and efficacy. The decision ensures its continued application in tablets, capsules, and other pharmaceutical formulations, where it provides opacity and stability.
Water-based Coatings